These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2751383)
21. [Occurrence and the sensitivity to drugs of fungi other than Candida albicans isolated from the vagina]. Pawlik B; Liber Z; Jurkowska E Med Dosw Mikrobiol; 1989; 41(1):60-6. PubMed ID: 2668661 [TBL] [Abstract][Full Text] [Related]
22. Effect of a novel phyto-compound on mucosal candidiasis: further evidence from an ex vivo study. Nakajima J; Papaah P; Yoshizawa M; Marotta F; Nakajima T; Mihara S; Minelli E J Dig Dis; 2007 Feb; 8(1):48-51. PubMed ID: 17261135 [TBL] [Abstract][Full Text] [Related]
23. [Susceptibility to nystatin of oral Candida isolates and its correlation with the response to treatment]. Santa Anna LM; Díaz Suárez LA; Illnait Zaragozí MT; Perurena Lancha MR; Cantelar de Francisco N; Fernández Andreu CM; Martínez Machín G Rev Cubana Med Trop; 2010; 62(3):237-44. PubMed ID: 23437555 [TBL] [Abstract][Full Text] [Related]
24. [Antimycotic sensitivities of the clinically isolated candidas]. Akgün Y; Akşit F Mikrobiyol Bul; 1981 Jul; 15(2):112-20. PubMed ID: 7052253 [TBL] [Abstract][Full Text] [Related]
25. [Yeast species identification in vulvovaginal candidiasis: susceptibility to nystatin]. Lisiak M; Kłyszejko C; Marcinkowski Z; Gwieździński Z Ginekol Pol; 2000 Sep; 71(9):959-63. PubMed ID: 11082956 [TBL] [Abstract][Full Text] [Related]
26. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin. Ellepola AN Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101 [TBL] [Abstract][Full Text] [Related]
27. [Role of fungi belonging to the genus Candida in the etiology of nonspecific pulmonary diseases]. Bahukova TA; Dobrodeeva LK Antibiot Khimioter; 1996 Jun; 41(6):44-8. PubMed ID: 9054329 [TBL] [Abstract][Full Text] [Related]
28. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP; Fan SR; Peng YT; Zhang HP J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725 [TBL] [Abstract][Full Text] [Related]
29. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B]. Fernández Andreu CM; Martínez Machin G; Illnait Zaragozi MT; Perurena Lancha MR; Aguila Sánchez A; Galloso Brito M Rev Cubana Med Trop; 2007; 59(2):113-8. PubMed ID: 23427444 [TBL] [Abstract][Full Text] [Related]
30. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
31. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
32. Rapid identification of fluconazole resistance using Chromagar Candida. Verghese SL; Padmaja P; Sutha P; Mathew T; John ES Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683 [TBL] [Abstract][Full Text] [Related]
33. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of a new automated system for the determination of antifungal sensitivity]. Lozano MC; Parras P; Martín E Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):135-8. PubMed ID: 8499512 [TBL] [Abstract][Full Text] [Related]
35. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin]. Suárez VL; Fernández Andreu CM Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917 [TBL] [Abstract][Full Text] [Related]
36. [Susceptibility to miconazole (base) of isolates from the oral cavity and esophagus of patients with mycosis]. Uchida K; Yamaguchi H Jpn J Antibiot; 1991 Mar; 44(3):357-64. PubMed ID: 1880917 [TBL] [Abstract][Full Text] [Related]
37. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027 [TBL] [Abstract][Full Text] [Related]
38. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A; J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Bremenkamp RM; Caris AR; Jorge AO; Back-Brito GN; Mota AJ; Balducci I; Brighenti FL; Koga-Ito CY Arch Oral Biol; 2011 Jun; 56(6):549-55. PubMed ID: 21183157 [TBL] [Abstract][Full Text] [Related]
40. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]